Accelerate Diagnostics Inc.

8.06-0.0300-0.37%Vol 194.03K1Y Perf -10.86%
Apr 16th, 2021 16:00 DELAYED
BID7.81 ASK8.47
Open8.19 Previous Close8.09
Pre-Market- After-Market8.06
 - -  - -%
Target Price
13.33 
Analyst Rating
Moderate Buy 2.33
Potential %
65.38 
Finscreener Ranking
★★★+     52.15
Insiders Trans % 3/6/12 mo.
-67/-71/38 
Value Ranking
★★★     50.81
Insiders Value % 3/6/12 mo.
-52/-62/87 
Growth Ranking
★★★★+     63.44
Insiders Shares Cnt. % 3/6/12 mo.
-43/-58/90 
Income Ranking
 —    -
Market Cap493.48M 
Earnings Rating
Buy
Price Range Ratio 52W %
10.09 
Earnings Date
6th May 2021

Today's Price Range

7.858.19

52W Range

6.8219.11

5 Year PE Ratio Range

-13.00-12.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-9.13%
1 Month
-12.39%
3 Months
-12.68%
6 Months
-30.64%
1 Year
-10.86%
3 Years
-67.37%
5 Years
-38.33%
10 Years
-

TickerPriceChg.Chg.%
AXDX8.06-0.0300-0.37
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
10.00
11.80
0.93
12.85
-4.00
Leverage Ratio -2.10
ProfitabilityValueIndustryS&P 500US Markets
39.90
-561.20
-534.30
-6 311.30
-
RevenueValueIndustryS&P 500US Markets
8.82M
0.14
38.48
131.32
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.31-0.33-6.45
Q03 2020-0.33-0.330.00
Q02 2020-0.34-0.35-2.94
Q01 2020-0.39-0.390.00
Q04 2019-0.43-0.399.30
Q03 2019-0.39-0.375.13
Q02 2019-0.40-0.385.00
Q01 2019-0.43-0.406.98
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.332.94Positive
6/2021 QR-0.325.88Positive
12/2021 FY-1.27-4.10Negative
12/2022 FY-0.91-13.75Negative
Next Report Date6th May 2021
Estimated EPS Next Report-0.33
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume194.03K
Shares Outstanding61.23M
Trades Count2.21K
Dollar Volume3.08M
Avg. Volume540.86K
Avg. Weekly Volume184.87K
Avg. Monthly Volume193.95K
Avg. Quarterly Volume581.65K

Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock closed at 8.06 per share at the end of the most recent trading day (a -0.37% change compared to the prior day closing price) with a volume of 194.95K shares and market capitalization of 493.48M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 275 people. Accelerate Diagnostics Inc. CEO is John Phillips.

The one-year performance of Accelerate Diagnostics Inc. stock is -10.86%, while year-to-date (YTD) performance is 6.33%. AXDX stock has a five-year performance of -38.33%. Its 52-week range is between 6.82 and 19.11, which gives AXDX stock a 52-week price range ratio of 10.09%

Accelerate Diagnostics Inc. currently has a PE ratio of -6.50, a price-to-book (PB) ratio of 89.93, a price-to-sale (PS) ratio of 57.74, a price to cashflow ratio of 213.80, a PEG ratio of 2.32, a ROA of -65.23%, a ROC of -51.28% and a ROE of 220.78%. The company’s profit margin is -%, its EBITDA margin is -534.30%, and its revenue ttm is $8.82 Million , which makes it $0.14 revenue per share.

Of the last four earnings reports from Accelerate Diagnostics Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.33 for the next earnings report. Accelerate Diagnostics Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Accelerate Diagnostics Inc. is Moderate Buy (2.33), with a target price of $13.33, which is +65.38% compared to the current price. The earnings rating for Accelerate Diagnostics Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accelerate Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accelerate Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.44, ATR14 : 0.89, CCI20 : -111.36, Chaikin Money Flow : -0.11, MACD : -0.81, Money Flow Index : 39.74, ROC : -0.86, RSI : 36.52, STOCH (14,3) : 16.05, STOCH RSI : 0.06, UO : 41.30, Williams %R : -83.95), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accelerate Diagnostics Inc. in the last 12-months were: Jack Phillips (Option Excercise at a value of $0), Jack Phillips (Sold 6 626 shares of value $72 223 ), Jack W Schuler (Buy at a value of $21 218 352), Romney Humphries (Option Excercise at a value of $53 370), Romney Humphries (Sold 9 000 shares of value $103 500 ), Steven Reichling (Option Excercise at a value of $327 800), Steven Reichling (Sold 110 000 shares of value $1 285 279 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Summary RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.33

Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

CEO: John Phillips

Telephone: +1 520 365-3100

Address: 3950 South Country Club Road, Tucson 85714, AZ, US

Number of employees: 275

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

71%29%

Bearish Bullish

60%40%

Bearish Bullish

59%41%

News

Stocktwits